ESAM and coronary artery disorder: In an atherosclerosis mouse model, estrogen can reduce atherosclerotic plaque burden (38), decrease the upregulation of endothelial cell adhesion molecules induced by cytokines, and reduce interleukin-6 expression, thereby inhibiting inflammation and reducing CHD incidence.